Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food Recall Warning (Allergen) - Northern King brand and Thai Gold brand Shrimp Tempura recalled due to undeclared egg, soy, milk, and sulphites


Product photos are available at: https://inspection.canada.ca/eng/1635537125574/1635537131395

OTTAWA, ON, Oct. 29, 2021 /CNW/ - TFI Foods Ltd. is recalling Northern King brand and Thai Gold brand Shrimp Tempura from the marketplace because they contain egg and may contain soy, milk, and sulphites which are not declared on the label. People with an allergy to egg, soy, or milk or a sensitivity to sulphites should not consume the recalled products described below.

The following products have been sold nationally.

Recalled products

Brand

Product

Size

UPC

Code

Northern King

Shrimp Tempura
26/30 ct/lb

600 g

0 61391 24216 5

All codes where egg, soy, milk, and sulphites are not declared on the label

Northern King

Shrimp Tempura
31/40 ct/lb

600 g

0 61391 12103 3

All codes where egg, soy, milk, and sulphites are not declared on the label

Northern King

Shrimp Tempura
31/40 ct/lb

500 g

0 61391 24242 4

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-on) 16/20 pieces/lb

1.135 kg

0 61391 22921 0

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-off) 16/20 pieces/lb

1.135 kg

0 61391 22923 4

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-on) 21/25 pieces/lb

1.135 kg

0 61391 24280 6

All codes where egg, soy, milk, and sulphites are not declared on the label

Thai Gold

Raw Tempura Battered Shrimp (Tail-on) 26/30 pieces/lb

1.135 kg

0 61391 24281 3

All codes where egg, soy, milk, and sulphites are not declared on the label

What you should do

Check to see if you have the recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to egg, soy, or milk or a sensitivity to sulphites, do not consume the recalled products as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Reactions

There have been no reported reactions associated with the consumption of these products.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: